[68Ga]-DOTATATE PET SUV Reduction After Bevacizumab in High-Grade Meningioma: A Potential Treatment Response Biomarker.
Saved in:
| Title: | [68Ga]-DOTATATE PET SUV Reduction After Bevacizumab in High-Grade Meningioma: A Potential Treatment Response Biomarker. |
|---|---|
| Authors: | Vu KV; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Otis HG; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Brandmaier A; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Osborne JR; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Stieg PE; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Ramakrishna RR; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Haghdel A; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Kim SH; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Liechty B; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Rosen K; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Beal K; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Pannullo SC; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Knisely JPS; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Magge RS; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Welch M; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Iwamoto F; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Pan PC; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA., Ivanidze J; From the MD Program (K.V.V., H.G.O.), Departments of Radiation Oncology (A.B., K.B., J.P.S.K.), Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Neurological Surgery (P.E.S., R. R.R., K.R.), Pathology (B.L.), Neuro-Oncology (R.S.M.),Weill Cornell Medicine, New York, NY, USA; Department of Neuro-Oncology (M.W., F.I., P.C.P.), Columbia University, New York, NY, USA. jai9018@med.cornell.edu. |
| Source: | AJNR. American journal of neuroradiology [AJNR Am J Neuroradiol] 2026 Feb 23. Date of Electronic Publication: 2026 Feb 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Neuroradiology Country of Publication: United States NLM ID: 8003708 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-959X (Electronic) Linking ISSN: 01956108 NLM ISO Abbreviation: AJNR Am J Neuroradiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
